Clinic Casting and Splinting Products Market Forecast to 2030 - Global Analysis by Product [Casting (Casts, Tapes, Cutters, and Casting Accessories) and Splinting (Splints and Splinting Accessories)], Application (Acute Fractures or Sprains, Tendon and Li

Clinic Casting and Splinting Products Market Forecast to 2030 - Global Analysis by Product [Casting (Casts, Tapes, Cutters, and Casting Accessories) and Splinting (Splints and Splinting Accessories)], Application (Acute Fractures or Sprains, Tendon and Ligament Injuries, and Others), and Material (Plaster of Paris, Fiberglass, and Others)

The global clinic casting and splinting products market was valued at US$ 1,383.42 million in 2022 and the clinic casting and splinting products market size is projected to reach US$ 2,085.57 million by 2030. It is expected to register a CAGR of 5.3% during the forecast period (2022-2030).

The rising prevalence of musculoskeletal conditions and high prevalence of age-related orthopedic disorders are the key driving factors behind the market development. Also, advancements in 3D technology in casting and splinting and rising adoption of fiberglass material for casting and splinting is expected to fuel the clinic casting and splinting products market in the upcoming years.

Rising Adoption of Fiberglass Material for Casting and Splinting is Responsible for Growth of the Clinic Casting and Splinting Products Market in the Upcoming Years

Fiberglass materials have the benefit of being lightweight and strong. In addition, these materials can be combined with waterproof liners to allow patients to bathe and swim in their casts. These materials are often more radiolucent, allowing better imaging within the cast. A typical fiberglass cast is made of three layers. The inner layer is a stockinette, which is a knitted fabric. The middle layer is a cotton bandage that is wrapped around the limb. The outermost layer is a resin and fiberglass composite activated and wrapped around the other layers. The purpose of the three layers is to provide support and protection for broken bones and skin. The fiberglass outer layer is hard and strong, and it helps keep the inner layers in place. The cotton bandage helps absorb any sweat or moisture that may build up under the cast, and the stockinette helps prevent the skin from rubbing against the rough edges of the fiberglass.

Fiberglass cast is made of light and incredibly strong material. The fiberglass casts are lightweight and have stronger construction, quicker curing time, reduced heat exposure, and radiolucency in the radiological image. The fiberglass is less dull as compared to plaster of Paris. Also, it is water resistant that helps patients avoid discomfort and constraints on daily activities. Additionally, fiberglass casts can help patients mobilize faster by allowing early weight-bearing due to their stronger construction. Casts made of fiberglass material require less maintenance than those made with plaster. The fiberglass is usually fitted when the bone is not out of position or when the healing process has already started. Therefore, fiberglass cast will be preferred over Plaster of Paris. Fiberglass materials form the hard supportive layer in cast and splints. Advances in casting and casting materials related to fiberglass, such as the use of fiberglass tape and polyester tape, offer high patient compliance in terms of ease of removal with a cast saw blade, smooth lamination, improved X-ray transparency, and availability in attractive colors and patterns, which is expected to significantly boost the adoption of fiberglass for casting and splinting products in the coming years.

Complications Related to Casting and Splinting Hamper Growth of Clinic Casting and Splinting Products Market

Internal fixation has become increasingly popular for fracture management and limb reconstruction. During the training, orthopedic surgeons may receive insufficient formal instruction on the art of extremity immobilization and cast application and removal. Casting has risks and complications such as stiffness, pressure sores, and compartment syndrome. Moreover, the risk of morbidity is higher when less experienced practitioners apply casts. The patients who are at high risk include obtunded or comatose multi-trauma patients, patients under anesthesia, developmentally delayed patients, and patients suffering from spasticity. Thus, the complications related to cast and splint hinder the clinic casting and splinting products market growth.

Clinic Casting and Splinting Products Market, By Product-Based Insights

The clinic casting and splinting products market, by product, is segmented into casting and splinting. The casting segment held a larger market share in 2022 because when it comes to serious fractures, orthopedic casts are usually the best option and they are typically made from stronger materials than splints, making them more durable and less likely to break or come loose. However, the splinting accessories segment is anticipated to register a higher CAGR during the forecast period.

Clinic Casting and Splinting Products Market, By Application-Based Insights

The clinic casting and splinting products market, by application, is segmented into acute fractures or sprains, tendon and ligament injuries, and others. The acute fractures or sprains segment held a larger market share in 2022 and is anticipated to register a higher CAGR during the forecast period.

Clinic Casting and Splinting Products Market, By Material-Based Insights

The clinic casting and splinting products market, by material, is segmented fiberglass, plaster of Paris, and others. The plaster of Paris segment held the largest share of the market in 2022. Due to its inexpensive cost, simplicity of application, and capacity to take the shape of the body part being immobilized, plaster of Paris is frequently used for casting and splinting applications. However, the fiberglass segment is anticipated to register the highest CAGR in the market during the forecast period.

A few of the major primary and secondary sources referred to while preparing the report on the clinic casting and splinting products market are the World Health Organization (WHO), Centers for Disease Control and Prevention (CDC), European Medical Agency (EMA), Pan American Health Organization (PAHO), National Osteoporosis Foundation of South Africa (NOFSA), and International Osteoporosis Foundation (IFO).

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the clinical casting and splinting products market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in the clinical casting and splinting products market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.